Hair-raising costs: Evaluating botulinum toxin treatment for androgenetic alopecia
Authors:
- 28 September 2024
- journal article
- letter
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 92 (1) , e25-e26
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Increased Interest in Oral Minoxidil for Hair Loss Treatment Following Publication of August 2022 New York Times Article: A Google Trends AnalysisSkin Appendage Disorders, 2023
- Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: A retrospective studyJournal of the American Academy of Dermatology, 2023
- Androgenetic Alopecia: Therapy UpdateDrugs, 2023
- Use of Botulinum Toxin for Androgenic Alopecia: A Systematic ReviewSkin Appendage Disorders, 2021